Lizano-Barrantes, Catalina https://orcid.org/0000-0003-1690-631X
Amat-Fernandez, Clara https://orcid.org/0000-0001-9595-0970
Garin, Olatz https://orcid.org/0000-0001-6193-0779
Luer-Aguila, Ricardo https://orcid.org/0009-0004-7730-0658
Pardo, Yolanda https://orcid.org/0000-0003-4982-5495
Rojas-Concha, Leslye https://orcid.org/0000-0002-6814-7426
Thong, Melissa S.Y. https://orcid.org/0000-0002-6987-705X
Apolone, Giovanni https://orcid.org/0000-0001-5179-104X
Brunelli, Cinzia https://orcid.org/0000-0003-3905-1289
Caraceni, Augusto https://orcid.org/0000-0002-0375-6204
Couespel, Norbert
Bos, Nanne
Groenvold, Mogens
Kaasa, Stein
Ciliberto, Gennaro https://orcid.org/0000-0003-2851-8605
Lombardo, Claudio https://orcid.org/0000-0001-7554-449X
Pietrobon, Ricardo
Pravettoni, Gabriella https://orcid.org/0000-0002-4843-4663
Sirven, Aude https://orcid.org/0009-0007-8222-0961
Vachon, Hugo https://orcid.org/0000-0003-1259-649X
Gilbert, Alexandra https://orcid.org/0000-0002-9142-1227
Velikova, Galina https://orcid.org/0000-0003-1899-5942
Ferrer, Montse https://orcid.org/0000-0001-9867-7391
,
Ciuleanu, Tudor
Mitrić, Milana
Ratosa, Ivica
Chovanec, Michal
Vieito, Maria
Aguilar, Héctor
Ruiz, Eva
Ahlberg, Karin
Simsek, Eda Tanrikulu
Gumus, Mahmut
van Braak, Inke
Higgins, Caitriona
Pinnavaia, Laura
Dantas, Carina
Kalmi, Tapani
Funding for this research was provided by:
Universitat Pompeu Fabra
Article History
Received: 11 April 2025
Accepted: 20 October 2025
First Online: 18 February 2026
Declarations
:
: The authors declare no competing interests in this study, except for author GV who declares honoraria from Pfizer, Novartis, Eisai and Lilly; Consultancy fees from AstraZeneca, Roche, Novartis, Pfizer, Seagen, Eisai and Sanofi, and an institutional grant from Pfizer.
: Ethical clearance and patient consent for this research is not required, as the systematic review only uses information from previously published research.